2-[1,4-bis(4-chlorophenyl)pyrazol-3-yl]oxy-n,n-dimethylethanamine (CHEM312629)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-08-29 14:33:04 UTC | ||||||||
| Update Date | 2026-08-29 14:33:04 UTC | ||||||||
| Accession Number | CHEM312629 | ||||||||
| Identification | |||||||||
| Common Name | 2-[1,4-bis(4-chlorophenyl)pyrazol-3-yl]oxy-n,n-dimethylethanamine | ||||||||
| Class | Small Molecule | ||||||||
| Description | 2-[1,4-bis(4-chlorophenyl)pyrazol-3-yl]oxy-n,n-dimethylethanamine is a chemical compound with the formula C19H19Cl2N3O. It has an average molecular weight of 376.30 g/mol. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C19H19Cl2N3O | ||||||||
| Average Molecular Mass | Not Available | ||||||||
| Monoisotopic Mass | 375.091 g/mol | ||||||||
| CAS Registry Number | Not Available | ||||||||
| IUPAC Name | 2-[1,4-bis(4-chlorophenyl)pyrazol-3-yl]oxy-n,n-dimethylethanamine | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CN(C)CCOC1=NN(C=C1C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl | ||||||||
| InChI Identifier | InChI=1S/C19H19Cl2N3O/c1-23(2)11-12-25-19-18(14-3-5-15(20)6-4-14)13-24(22-19)17-9-7-16(21)8-10-17/h3-10,13H,11-12H2,1-2H3 | ||||||||
| InChI Key | CQRIQGDBZCFCBC-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
